Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gcm1
|
ENSMUSG00000023333.7 | glial cells missing homolog 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_78059834_78059985 | Gcm1 | 7985 | 0.113308 | -0.30 | 2.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_66240081_66240411 | 23.99 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
45805 |
0.14 |
chr6_55680988_55681310 | 15.20 |
Neurod6 |
neurogenic differentiation 6 |
114 |
0.97 |
chr3_26003308_26003504 | 11.79 |
Nlgn1 |
neuroligin 1 |
130328 |
0.06 |
chr14_14350947_14351733 | 11.22 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr11_117408465_117408630 | 10.70 |
Gm11729 |
predicted gene 11729 |
5842 |
0.16 |
chr2_153425549_153426538 | 10.54 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr13_34133930_34134147 | 10.03 |
Gm36500 |
predicted gene, 36500 |
178 |
0.9 |
chr7_25006131_25006556 | 9.58 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
385 |
0.75 |
chr1_5018013_5019021 | 9.37 |
Rgs20 |
regulator of G-protein signaling 20 |
218 |
0.93 |
chr5_9338937_9339167 | 9.23 |
Gm15733 |
predicted gene 15733 |
14707 |
0.19 |
chr5_116591724_116592384 | 8.73 |
Srrm4 |
serine/arginine repetitive matrix 4 |
237 |
0.93 |
chr14_19986647_19987041 | 8.54 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
9217 |
0.21 |
chr1_165934649_165934837 | 7.75 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
157 |
0.94 |
chr11_8456656_8457180 | 7.51 |
Tns3 |
tensin 3 |
11757 |
0.29 |
chr15_85652871_85653067 | 7.49 |
Lncppara |
long noncoding RNA near Ppara |
647 |
0.66 |
chr4_46991653_46992403 | 7.28 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
155 |
0.95 |
chr5_111414144_111414882 | 7.23 |
Mn1 |
meningioma 1 |
2849 |
0.22 |
chr4_140246139_140246416 | 7.20 |
Igsf21 |
immunoglobulin superfamily, member 21 |
507 |
0.83 |
chr13_92734166_92734374 | 7.08 |
Gm5199 |
predicted gene 5199 |
14908 |
0.19 |
chr17_10451515_10451727 | 6.89 |
A230009B12Rik |
RIKEN cDNA A230009B12 gene |
4595 |
0.29 |
chr8_112269835_112269986 | 6.84 |
Gm3635 |
predicted gene 3635 |
32944 |
0.22 |
chr9_23487032_23487234 | 6.82 |
Bmper |
BMP-binding endothelial regulator |
113201 |
0.07 |
chr12_28816927_28817125 | 6.68 |
Gm48905 |
predicted gene, 48905 |
6888 |
0.18 |
chr4_119338861_119339361 | 6.68 |
Ldha-ps2 |
lactate dehydrogenase A, pseudogene 2 |
3666 |
0.13 |
chr3_84285674_84285827 | 6.30 |
Trim2 |
tripartite motif-containing 2 |
14959 |
0.24 |
chr12_30372910_30373696 | 6.19 |
Sntg2 |
syntrophin, gamma 2 |
8 |
0.98 |
chr19_41690014_41690230 | 6.16 |
Slit1 |
slit guidance ligand 1 |
53364 |
0.12 |
chr13_8203184_8203444 | 6.07 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
392 |
0.84 |
chr15_45114150_45114339 | 6.05 |
Kcnv1 |
potassium channel, subfamily V, member 1 |
583 |
0.82 |
chr13_47708144_47708298 | 6.00 |
4930471G24Rik |
RIKEN cDNA 4930471G24 gene |
40671 |
0.21 |
chr8_87702762_87703444 | 6.00 |
Zfp423 |
zinc finger protein 423 |
100720 |
0.07 |
chr18_35676191_35676484 | 5.98 |
Dnajc18 |
DnaJ heat shock protein family (Hsp40) member C18 |
10406 |
0.08 |
chr2_33355615_33355975 | 5.82 |
Gm25998 |
predicted gene, 25998 |
7251 |
0.17 |
chr17_73487523_73487674 | 5.69 |
Gm49876 |
predicted gene, 49876 |
6653 |
0.19 |
chr8_66687682_66688171 | 5.64 |
Npy5r |
neuropeptide Y receptor Y5 |
121 |
0.97 |
chr6_109150923_109151122 | 5.58 |
Gm29781 |
predicted gene, 29781 |
25337 |
0.23 |
chr13_92733870_92734066 | 5.57 |
Gm5199 |
predicted gene 5199 |
14606 |
0.19 |
chr6_36644686_36644907 | 5.56 |
Gm2189 |
predicted gene 2189 |
4530 |
0.27 |
chr9_26690126_26690338 | 5.53 |
Gm48393 |
predicted gene, 48393 |
40942 |
0.15 |
chr7_75999434_75999585 | 5.45 |
Gm45139 |
predicted gene 45139 |
1315 |
0.55 |
chr4_83233208_83233369 | 5.41 |
Ttc39b |
tetratricopeptide repeat domain 39B |
118 |
0.97 |
chr17_15380918_15381780 | 5.41 |
Dll1 |
delta like canonical Notch ligand 1 |
4477 |
0.18 |
chr1_32172491_32172820 | 5.40 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
59 |
0.98 |
chr2_96318005_96318352 | 5.38 |
Lrrc4c |
leucine rich repeat containing 4C |
9 |
0.99 |
chr13_34575671_34575928 | 5.37 |
Gm36758 |
predicted gene, 36758 |
13813 |
0.16 |
chr2_50971612_50971823 | 5.37 |
Gm13498 |
predicted gene 13498 |
62033 |
0.14 |
chr10_39471788_39472014 | 5.33 |
Fyn |
Fyn proto-oncogene |
16986 |
0.2 |
chr17_43157845_43158231 | 5.31 |
E130008D07Rik |
RIKEN cDNA E130008D07 gene |
158 |
0.97 |
chr5_53161608_53161853 | 5.26 |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
5050 |
0.22 |
chr2_113828734_113829247 | 5.24 |
Scg5 |
secretogranin V |
131 |
0.96 |
chr5_45639206_45639588 | 5.22 |
9630001P10Rik |
RIKEN cDNA 9630001P10 gene |
16 |
0.73 |
chr6_134888153_134888812 | 5.20 |
Gpr19 |
G protein-coupled receptor 19 |
650 |
0.56 |
chr1_21078652_21079573 | 5.16 |
Tram2 |
translocating chain-associating membrane protein 2 |
117 |
0.93 |
chr4_9595769_9595927 | 5.15 |
Asph |
aspartate-beta-hydroxylase |
159 |
0.97 |
chr6_114258062_114258247 | 5.13 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
24481 |
0.21 |
chr8_3499866_3501209 | 5.09 |
Mcoln1 |
mucolipin 1 |
3 |
0.96 |
chr8_4492910_4494136 | 5.09 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr10_46718838_46719012 | 5.06 |
Gm19994 |
predicted gene, 19994 |
48781 |
0.16 |
chr10_105110471_105110625 | 5.00 |
Gm25422 |
predicted gene, 25422 |
29787 |
0.17 |
chr4_46991096_46991621 | 5.00 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
515 |
0.76 |
chr14_64590760_64591006 | 4.98 |
Mir124a-1 |
microRNA 124a-1 |
226 |
0.56 |
chr19_53528895_53529902 | 4.96 |
Gm50394 |
predicted gene, 50394 |
257 |
0.52 |
chr2_49672278_49672906 | 4.95 |
Gm13525 |
predicted gene 13525 |
7907 |
0.24 |
chr10_66574947_66575098 | 4.90 |
Gm28139 |
predicted gene 28139 |
65896 |
0.11 |
chr19_15790953_15791211 | 4.89 |
Gm50348 |
predicted gene, 50348 |
11976 |
0.27 |
chrX_155623403_155623925 | 4.89 |
Ptchd1 |
patched domain containing 1 |
150 |
0.88 |
chr10_14332669_14332906 | 4.88 |
Gm48854 |
predicted gene, 48854 |
5376 |
0.19 |
chr1_106402912_106403063 | 4.86 |
A530053M12Rik |
RIKEN cDNA A530053M12 gene |
1000 |
0.6 |
chr3_121700295_121700994 | 4.85 |
Gm43608 |
predicted gene 43608 |
9602 |
0.11 |
chr2_3168854_3169013 | 4.82 |
Fam171a1 |
family with sequence similarity 171, member A1 |
50248 |
0.13 |
chr8_84793716_84794468 | 4.82 |
Nfix |
nuclear factor I/X |
5932 |
0.1 |
chr7_37337466_37337617 | 4.81 |
6720469O03Rik |
RIKEN cDNA 6720469O03 gene |
29089 |
0.19 |
chr17_37048040_37048695 | 4.80 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
211 |
0.86 |
chr11_116919017_116919181 | 4.78 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
236 |
0.91 |
chr12_17097705_17098267 | 4.76 |
Gm48538 |
predicted gene, 48538 |
32573 |
0.16 |
chr4_148436048_148436378 | 4.75 |
Gm23303 |
predicted gene, 23303 |
7272 |
0.14 |
chr4_49041678_49042070 | 4.71 |
Plppr1 |
phospholipid phosphatase related 1 |
17399 |
0.23 |
chr10_71284478_71285120 | 4.71 |
Ube2d1 |
ubiquitin-conjugating enzyme E2D 1 |
419 |
0.75 |
chr13_40704341_40704518 | 4.64 |
Gm9979 |
predicted gene 9979 |
424 |
0.75 |
chr4_101508891_101509449 | 4.62 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
1140 |
0.54 |
chr15_4100684_4100835 | 4.62 |
Gm15632 |
predicted gene 15632 |
28727 |
0.16 |
chr3_118443749_118443941 | 4.61 |
Gm9916 |
predicted gene 9916 |
9075 |
0.15 |
chr11_8863773_8864261 | 4.61 |
Pkd1l1 |
polycystic kidney disease 1 like 1 |
133 |
0.97 |
chr15_102583680_102583842 | 4.60 |
Atf7 |
activating transcription factor 7 |
41161 |
0.07 |
chr5_148398815_148400002 | 4.59 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
383 |
0.89 |
chr9_124439906_124440949 | 4.58 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr15_84621838_84622005 | 4.57 |
Gm34095 |
predicted gene, 34095 |
44804 |
0.12 |
chr12_25865114_25865299 | 4.56 |
Gm47733 |
predicted gene, 47733 |
5947 |
0.28 |
chr18_38177400_38177569 | 4.55 |
Pcdh1 |
protocadherin 1 |
25679 |
0.12 |
chr11_118739444_118739596 | 4.54 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
21521 |
0.2 |
chr1_167660571_167661124 | 4.54 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
28390 |
0.21 |
chr16_95119337_95119488 | 4.46 |
Gm49641 |
predicted gene, 49641 |
17008 |
0.22 |
chr8_71469378_71469964 | 4.46 |
Dda1 |
DET1 and DDB1 associated 1 |
386 |
0.69 |
chr5_113490480_113490843 | 4.42 |
Wscd2 |
WSC domain containing 2 |
91 |
0.98 |
chr18_55427689_55427840 | 4.41 |
Gm37828 |
predicted gene, 37828 |
88252 |
0.09 |
chr18_54379557_54379730 | 4.40 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
42652 |
0.18 |
chr14_34823193_34823513 | 4.39 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
3245 |
0.25 |
chr7_65577161_65577493 | 4.36 |
BC046251 |
cDNA sequence BC046251 |
4743 |
0.22 |
chr8_36155388_36156182 | 4.30 |
Gm38414 |
predicted gene, 38414 |
225 |
0.92 |
chrX_136708182_136708427 | 4.27 |
Tceal1 |
transcription elongation factor A (SII)-like 1 |
322 |
0.83 |
chr13_73117493_73117685 | 4.26 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
115806 |
0.06 |
chr6_127683706_127683857 | 4.26 |
Gm43634 |
predicted gene 43634 |
39341 |
0.12 |
chrX_42359349_42359685 | 4.25 |
Gm14619 |
predicted gene 14619 |
12005 |
0.28 |
chr14_88464462_88464613 | 4.24 |
Pcdh20 |
protocadherin 20 |
6809 |
0.24 |
chr16_72610904_72611128 | 4.23 |
Robo1 |
roundabout guidance receptor 1 |
47316 |
0.2 |
chr8_61443233_61443384 | 4.22 |
Cbr4 |
carbonyl reductase 4 |
44426 |
0.13 |
chr19_30548853_30549010 | 4.20 |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
734 |
0.63 |
chr3_30207571_30207746 | 4.19 |
Gm38197 |
predicted gene, 38197 |
20036 |
0.16 |
chr11_61453860_61454171 | 4.14 |
Rnf112 |
ring finger protein 112 |
10 |
0.96 |
chr9_90490877_90491030 | 4.12 |
Gm22866 |
predicted gene, 22866 |
138958 |
0.04 |
chr3_34666881_34667083 | 4.12 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1739 |
0.22 |
chr18_23869070_23869542 | 4.11 |
Gm23207 |
predicted gene, 23207 |
51935 |
0.1 |
chr7_24486621_24486807 | 4.11 |
Cadm4 |
cell adhesion molecule 4 |
4691 |
0.1 |
chr4_143379335_143379486 | 4.10 |
Anp32b-ps1 |
Bacidic (leucine-rich) nuclear phosphoprotein 32 family, member B, pseudogene 1 |
10249 |
0.11 |
chr7_79518540_79518758 | 4.10 |
Gm37608 |
predicted gene, 37608 |
1767 |
0.18 |
chr19_22303662_22303830 | 4.10 |
Gm22506 |
predicted gene, 22506 |
68128 |
0.12 |
chr9_50306008_50306447 | 4.09 |
Gm39336 |
predicted gene, 39336 |
4410 |
0.23 |
chr7_88129633_88129787 | 4.08 |
Gm44846 |
predicted gene 44846 |
10552 |
0.2 |
chr1_34579595_34579789 | 4.07 |
1700101I19Rik |
RIKEN cDNA 1700101I19 gene |
19 |
0.5 |
chr15_81937343_81937785 | 4.05 |
Csdc2 |
cold shock domain containing C2, RNA binding |
582 |
0.55 |
chr1_112379892_112380215 | 4.05 |
Gm18406 |
predicted gene, 18406 |
24802 |
0.25 |
chr15_95527932_95528173 | 4.05 |
Nell2 |
NEL-like 2 |
126 |
0.98 |
chr7_79543495_79543979 | 4.03 |
Gm35040 |
predicted gene, 35040 |
7694 |
0.09 |
chr16_39151948_39152099 | 4.00 |
Gm36742 |
predicted gene, 36742 |
36883 |
0.21 |
chr2_181680327_181681099 | 4.00 |
Tcea2 |
transcription elongation factor A (SII), 2 |
403 |
0.7 |
chr4_9551872_9552064 | 3.98 |
Asph |
aspartate-beta-hydroxylase |
43721 |
0.17 |
chr10_52940840_52940991 | 3.98 |
Gm25664 |
predicted gene, 25664 |
35277 |
0.19 |
chr11_94160820_94161321 | 3.97 |
B230206L02Rik |
RIKEN cDNA B230206L02 gene |
25410 |
0.16 |
chrX_135210164_135210824 | 3.97 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
193 |
0.92 |
chr6_82939285_82939948 | 3.95 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
71 |
0.94 |
chr10_14082412_14082585 | 3.94 |
Gm28289 |
predicted gene 28289 |
71948 |
0.09 |
chr12_119238190_119238959 | 3.93 |
Itgb8 |
integrin beta 8 |
196 |
0.95 |
chr4_130861388_130861557 | 3.90 |
Gm22660 |
predicted gene, 22660 |
3592 |
0.18 |
chr5_101959428_101959584 | 3.90 |
Gm42934 |
predicted gene 42934 |
2899 |
0.28 |
chr11_7063253_7063434 | 3.90 |
Adcy1 |
adenylate cyclase 1 |
146 |
0.97 |
chr4_109202699_109202856 | 3.89 |
Osbpl9 |
oxysterol binding protein-like 9 |
505 |
0.81 |
chr3_68870013_68870633 | 3.89 |
Gm17641 |
predicted gene, 17641 |
57 |
0.91 |
chr18_25525761_25525937 | 3.88 |
Celf4 |
CUGBP, Elav-like family member 4 |
24610 |
0.23 |
chr2_181159175_181159525 | 3.87 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
2336 |
0.17 |
chr9_110624084_110624819 | 3.87 |
Nradd |
neurotrophin receptor associated death domain |
1 |
0.96 |
chr4_126465849_126466306 | 3.85 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2344 |
0.19 |
chr7_89140693_89141295 | 3.85 |
Tmem135 |
transmembrane protein 135 |
4503 |
0.3 |
chr11_118202938_118203161 | 3.84 |
Gm11737 |
predicted gene 11737 |
2130 |
0.25 |
chr2_38621804_38622039 | 3.82 |
Gm13586 |
predicted gene 13586 |
880 |
0.48 |
chr10_56115250_56115679 | 3.81 |
Msl3l2 |
MSL3 like 2 |
549 |
0.8 |
chr12_86786225_86786409 | 3.79 |
Lrrc74a |
leucine rich repeat containing 74A |
45310 |
0.11 |
chr4_5724163_5724370 | 3.78 |
Fam110b |
family with sequence similarity 110, member B |
46 |
0.98 |
chr17_32536233_32536620 | 3.77 |
Cyp4f16 |
cytochrome P450, family 4, subfamily f, polypeptide 16 |
132 |
0.94 |
chr4_13399180_13399442 | 3.77 |
Gm11819 |
predicted gene 11819 |
45459 |
0.18 |
chr8_63952005_63952350 | 3.76 |
Sgo2b |
shugoshin 2B |
7 |
0.98 |
chr1_5019296_5020184 | 3.76 |
Rgs20 |
regulator of G-protein signaling 20 |
201 |
0.93 |
chr13_69862520_69862693 | 3.76 |
Med10 |
mediator complex subunit 10 |
51021 |
0.11 |
chr3_125937638_125938666 | 3.76 |
Ugt8a |
UDP galactosyltransferase 8A |
399 |
0.92 |
chr4_136793528_136793702 | 3.75 |
Ephb2 |
Eph receptor B2 |
42228 |
0.14 |
chr6_41620533_41620720 | 3.75 |
Ephb6 |
Eph receptor B6 |
683 |
0.56 |
chr2_66043737_66043907 | 3.74 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
50249 |
0.13 |
chr6_134207480_134208194 | 3.74 |
Etv6 |
ets variant 6 |
25763 |
0.14 |
chr7_144895075_144895226 | 3.73 |
Fgf15 |
fibroblast growth factor 15 |
1381 |
0.26 |
chr8_122751278_122751680 | 3.73 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
846 |
0.44 |
chr6_91412065_91412228 | 3.70 |
Gm30437 |
predicted gene, 30437 |
633 |
0.43 |
chr17_3611352_3611547 | 3.70 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53580 |
0.12 |
chr1_42684074_42684488 | 3.69 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
8812 |
0.14 |
chr8_35605443_35605594 | 3.66 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
1759 |
0.36 |
chr8_18702245_18702542 | 3.64 |
Angpt2 |
angiopoietin 2 |
2846 |
0.25 |
chr8_122803662_122803836 | 3.59 |
Gm45743 |
predicted gene 45743 |
22337 |
0.08 |
chr12_26903343_26903933 | 3.58 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
68765 |
0.13 |
chr11_95587163_95587488 | 3.55 |
Ngfr |
nerve growth factor receptor (TNFR superfamily, member 16) |
410 |
0.83 |
chr17_32023134_32023285 | 3.55 |
Hsf2bp |
heat shock transcription factor 2 binding protein |
4 |
0.97 |
chr17_36083165_36083938 | 3.53 |
H2-Bl |
histocompatibility 2, blastocyst |
642 |
0.37 |
chr17_65146475_65146626 | 3.53 |
Gm49865 |
predicted gene, 49865 |
22653 |
0.26 |
chr10_59958140_59958359 | 3.52 |
Ddit4 |
DNA-damage-inducible transcript 4 |
6415 |
0.18 |
chr10_4712380_4712918 | 3.52 |
Esr1 |
estrogen receptor 1 (alpha) |
2 |
0.99 |
chr7_18950757_18950953 | 3.50 |
Nova2 |
NOVA alternative splicing regulator 2 |
24967 |
0.07 |
chr15_74672233_74673425 | 3.49 |
Arc |
activity regulated cytoskeletal-associated protein |
259 |
0.85 |
chr15_88290879_88291033 | 3.49 |
B230214G05Rik |
RIKEN cDNA B230214G05 gene |
23918 |
0.21 |
chr11_32623302_32623467 | 3.49 |
Fbxw11 |
F-box and WD-40 domain protein 11 |
19340 |
0.19 |
chr2_30692288_30692565 | 3.49 |
Gm14486 |
predicted gene 14486 |
14415 |
0.14 |
chr4_41685200_41685372 | 3.47 |
Cntfr |
ciliary neurotrophic factor receptor |
10156 |
0.09 |
chr12_29790110_29790303 | 3.44 |
Myt1l |
myelin transcription factor 1-like |
50004 |
0.17 |
chr7_44427795_44428672 | 3.43 |
Lrrc4b |
leucine rich repeat containing 4B |
785 |
0.39 |
chr14_71241998_71242637 | 3.43 |
Gm4251 |
predicted gene 4251 |
8956 |
0.29 |
chr16_30130234_30130394 | 3.43 |
Gm6029 |
predicted gene 6029 |
9145 |
0.15 |
chrX_73503102_73503589 | 3.42 |
Atp2b3 |
ATPase, Ca++ transporting, plasma membrane 3 |
259 |
0.88 |
chr4_65610954_65611238 | 3.41 |
Trim32 |
tripartite motif-containing 32 |
5847 |
0.35 |
chr3_101404757_101404985 | 3.40 |
Gm42939 |
predicted gene 42939 |
2922 |
0.2 |
chr2_70202586_70203174 | 3.39 |
Myo3b |
myosin IIIB |
106582 |
0.06 |
chr1_66227054_66227223 | 3.36 |
Map2 |
microtubule-associated protein 2 |
24509 |
0.21 |
chr14_103648596_103649209 | 3.35 |
Slain1 |
SLAIN motif family, member 1 |
1326 |
0.39 |
chr10_75892899_75893716 | 3.35 |
Derl3 |
Der1-like domain family, member 3 |
106 |
0.92 |
chr11_12232419_12232735 | 3.34 |
Gm12002 |
predicted gene 12002 |
81937 |
0.09 |
chr2_151701768_151703133 | 3.33 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr1_166304269_166304463 | 3.32 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
5219 |
0.2 |
chr12_52010002_52010599 | 3.32 |
Dtd2 |
D-tyrosyl-tRNA deacylase 2 |
3799 |
0.19 |
chr11_114792016_114792508 | 3.30 |
Btbd17 |
BTB (POZ) domain containing 17 |
3611 |
0.16 |
chr11_97573860_97574076 | 3.30 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
24 |
0.96 |
chr15_73839648_73839846 | 3.30 |
Mroh5 |
maestro heat-like repeat family member 5 |
48 |
0.97 |
chr13_34134243_34134554 | 3.29 |
Gm36500 |
predicted gene, 36500 |
538 |
0.63 |
chr10_73099176_73099696 | 3.29 |
Pcdh15 |
protocadherin 15 |
1 |
0.98 |
chr13_83988136_83988456 | 3.28 |
Gm4241 |
predicted gene 4241 |
305 |
0.91 |
chr7_113052920_113053071 | 3.28 |
Gm23662 |
predicted gene, 23662 |
66703 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.8 | 14.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.8 | 7.3 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.8 | 5.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.2 | 3.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.2 | 2.4 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.2 | 3.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.0 | 4.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.0 | 4.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.0 | 3.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.0 | 15.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.0 | 3.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.9 | 2.6 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.8 | 2.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.8 | 1.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.8 | 3.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 3.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.7 | 6.7 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.6 | 1.9 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 1.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.6 | 1.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.6 | 12.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 1.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 1.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.5 | 1.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 1.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.5 | 2.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 2.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 2.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.5 | 2.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 1.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 3.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 0.9 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.4 | 0.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 | 1.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 1.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 2.2 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.4 | 1.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 3.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.4 | 3.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 1.7 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 4.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 1.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 3.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 1.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 13.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.2 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.4 | 4.3 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 3.1 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.4 | 1.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 1.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 2.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 1.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.4 | 1.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 1.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.9 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.2 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.3 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 1.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 4.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 1.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 3.0 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 0.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.6 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.3 | 0.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 0.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 0.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 3.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 2.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 2.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 1.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 2.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.7 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 1.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 2.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 1.0 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.2 | 0.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 1.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 3.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 3.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.2 | 0.7 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 1.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 0.9 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 3.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 4.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 1.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 1.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 0.2 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 1.9 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 3.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 1.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 0.8 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.2 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 1.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.2 | 3.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.2 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 0.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 1.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.5 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 1.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 1.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 1.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.3 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 1.8 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 1.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.9 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 3.5 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 0.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.5 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 1.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 1.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 1.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.1 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 2.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.3 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.3 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 3.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 5.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.4 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 1.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.2 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 2.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 1.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 1.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 1.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.3 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 1.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 2.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 1.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 2.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 1.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 2.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.1 | 0.3 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 1.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 1.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.1 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 2.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 1.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.1 | 1.4 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.2 | GO:0098597 | observational learning(GO:0098597) |
0.1 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.3 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 3.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 1.2 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.9 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 1.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.5 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.4 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.1 | 0.8 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.5 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 2.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.3 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.2 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 1.0 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0044321 | response to leptin(GO:0044321) |
0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.6 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.2 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 1.0 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.4 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.2 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.1 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.7 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 1.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.6 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 3.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.3 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 1.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.0 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 1.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.0 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.1 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.0 | 0.1 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.0 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.1 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.4 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.0 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.0 | 1.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.0 | 0.0 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.0 | 0.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.5 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.0 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.0 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 2.3 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.7 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.1 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.8 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 1.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.1 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.0 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.2 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 1.6 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.6 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 1.4 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.0 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.0 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 1.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.0 | 0.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.0 | 0.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.0 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 14.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.4 | 5.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 5.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 11.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.8 | 2.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 2.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 6.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 2.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.5 | 1.4 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 1.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.4 | 2.6 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 3.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 6.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.8 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 1.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 2.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 8.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 4.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 2.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 2.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 3.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 2.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 5.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 1.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 3.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 2.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 15.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 3.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.8 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 4.8 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.0 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 1.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 5.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 2.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 3.5 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 2.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0005818 | aster(GO:0005818) |
0.0 | 0.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 15.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.0 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.0 | 6.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.7 | 5.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.5 | 4.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.4 | 5.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
1.2 | 3.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.0 | 3.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.9 | 3.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 11.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 4.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.8 | 7.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.8 | 4.1 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.8 | 2.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.8 | 5.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 2.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 3.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.6 | 2.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 2.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 2.7 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 3.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 1.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 2.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 2.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 1.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 2.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 6.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.5 | 2.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 2.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 4.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 1.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 4.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 2.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.4 | 1.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 0.9 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 1.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 3.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 2.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.8 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 2.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 8.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 2.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 7.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 2.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.3 | 5.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 0.7 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 1.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 1.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 4.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 2.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 3.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 1.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 4.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 3.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 18.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 4.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 3.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 1.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 2.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 2.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 2.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 7.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 1.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 2.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 1.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 2.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.9 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.0 | 1.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0018857 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 2.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.8 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 1.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 2.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.4 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.2 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 1.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.0 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 1.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.0 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 9.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 11.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 3.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 3.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 7.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 3.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 2.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 3.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 4.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 2.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 16.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 11.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 3.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 4.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 3.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 13.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 6.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 9.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 2.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 2.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 4.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 4.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 1.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 4.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 3.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 2.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 3.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 4.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 3.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 2.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 1.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 1.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 2.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |